MDT · Medtronic plc

Summary

Medtronic plc announced Q3 FY26 financial results with $9.017 billion revenue, up 8.7% reported and 6.0% organic, and non-GAAP diluted EPS of $1.36, both ahead of guidance. The company reiterates FY26 organic revenue growth of approximately 5.5% and non-GAAP diluted EPS guidance of $5.62 to $5.66.